135 related articles for article (PubMed ID: 30464604)
1. NSAID consumption and risk of acute myeloid leukemia: a national population-based case-control study.
Østgård LSG; Nørgaard M; Pedersen L; Østgård R; Friis LS; Schöllkopf C; Severinsen MT; Marcher CW; Medeiros BC; Jensen MK
Cancer Manag Res; 2018; 10():5043-5051. PubMed ID: 30464604
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune diseases, infections, use of antibiotics and the risk of acute myeloid leukaemia: a national population-based case-control study.
Østgård LSG; Nørgaard M; Pedersen L; Østgård RD; Medeiros BC; Overgaard UM; Schöllkopf C; Severinsen M; Marcher CW; Jensen MK
Br J Haematol; 2018 Apr; 181(2):205-214. PubMed ID: 29504124
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drug and acetaminophen use and risk of adult myeloid leukemia.
Ross JA; Blair CK; Cerhan JR; Soler JT; Hirsch BA; Roesler MA; Higgins RR; Nguyen PL
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1741-50. PubMed ID: 21715605
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06.
Caprioli C; Lussana F; Salmoiraghi S; Cavagna R; Buklijas K; Elidi L; Zanghi' P; Michelato A; Delaini F; Oldani E; Intermesoli T; Grassi A; Gianfaldoni G; Mannelli F; Ferrero D; Audisio E; Terruzzi E; De Paoli L; Cattaneo C; Borlenghi E; Cavattoni I; Tajana M; Scattolin AM; Mattei D; Corradini P; Campiotti L; Ciceri F; Bernardi M; Todisco E; Cortelezzi A; Falini B; Pavoni C; Bassan R; Spinelli O; Rambaldi A
Haematologica; 2021 Oct; 106(10):2578-2587. PubMed ID: 32855275
[TBL] [Abstract][Full Text] [Related]
6. Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia.
Schmaelter AK; Labopin M; Socié G; Itälä-Remes M; Blaise D; Yakoub-Agha I; Forcade E; Cornelissen J; Ganser A; Beelen D; Labussière-Wallet H; Passweg J; Savani BN; Schmid C; Nagler A; Mohty M
Blood Cancer J; 2020 Mar; 10(3):26. PubMed ID: 32127519
[TBL] [Abstract][Full Text] [Related]
7. Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease.
Collinge E; Loron S; Larcher MV; Elhamri M; Heiblig M; Deloire A; Ducastelle S; Labussière H; Barraco F; Wattel E; Salles G; Paubelle E; Thomas X
Clin Lymphoma Myeloma Leuk; 2018 May; 18(5):e211-e218. PubMed ID: 29572159
[TBL] [Abstract][Full Text] [Related]
8. Challenges in the diagnosis and treatment of secondary acute myeloid leukemia.
Ossenkoppele G; Montesinos P
Crit Rev Oncol Hematol; 2019 Jun; 138():6-13. PubMed ID: 31092386
[TBL] [Abstract][Full Text] [Related]
9. A hospital-based case-control study of acute myeloid leukemia in Shanghai: analysis of personal characteristics, lifestyle and environmental risk factors by subtypes of the WHO classification.
Wong O; Harris F; Yiying W; Hua F
Regul Toxicol Pharmacol; 2009 Dec; 55(3):340-52. PubMed ID: 19703505
[TBL] [Abstract][Full Text] [Related]
10. Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry.
Hulegårdh E; Nilsson C; Lazarevic V; Garelius H; Antunovic P; Rangert Derolf Å; Möllgård L; Uggla B; Wennström L; Wahlin A; Höglund M; Juliusson G; Stockelberg D; Lehmann S
Am J Hematol; 2015 Mar; 90(3):208-14. PubMed ID: 25421221
[TBL] [Abstract][Full Text] [Related]
11. Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study.
Shu XO; Ross JA; Pendergrass TW; Reaman GH; Lampkin B; Robison LL
J Natl Cancer Inst; 1996 Jan; 88(1):24-31. PubMed ID: 8847721
[TBL] [Abstract][Full Text] [Related]
12. Characterization and prognostic features of secondary acute myeloid leukemia in survivors of multiple myeloma.
Jia J; Chen W
Am J Cancer Res; 2023; 13(10):4803-4810. PubMed ID: 37970345
[TBL] [Abstract][Full Text] [Related]
13. Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Ertz-Archambault N; Kosiorek H; Taylor GE; Kelemen K; Dueck A; Castro J; Marino R; Gauthier S; Finn L; Sproat LZ; Palmer J; Mesa RA; Al-Kali A; Foran J; Tibes R
JAMA Oncol; 2017 Jul; 3(7):936-943. PubMed ID: 28152123
[TBL] [Abstract][Full Text] [Related]
14. Prescription drug use and risk of acute myeloid leukemia by French-American-British subtype: results from a Los Angeles County case-control study.
Pogoda JM; Katz J; McKean-Cowdin R; Nichols PW; Ross RK; Preston-Martin S
Int J Cancer; 2005 Apr; 114(4):634-8. PubMed ID: 15609330
[TBL] [Abstract][Full Text] [Related]
15. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes.
Kristinsson SY; Björkholm M; Hultcrantz M; Derolf ÅR; Landgren O; Goldin LR
J Clin Oncol; 2011 Jul; 29(21):2897-903. PubMed ID: 21690473
[TBL] [Abstract][Full Text] [Related]
16. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
Larson RA
Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal Anti-Inflammatory Drug Prescriptions Are Associated With Increased Stress Fracture Diagnosis in the US Army Population.
Hughes JM; McKinnon CJ; Taylor KM; Kardouni JR; Bulathsinhala L; Guerriere KI; Popp KL; Bouxsein ML; Proctor SP; Matheny RW
J Bone Miner Res; 2019 Mar; 34(3):429-436. PubMed ID: 30352135
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AML.
de Nully Brown P; Hoffmann T; Hansen OP; Boesen AM; Grønbaek K; Hippe E; Jensen MK; Thorling K; Storm HH; Pedersen-Bjergaard J
Leukemia; 1997 Jan; 11(1):37-41. PubMed ID: 9001416
[TBL] [Abstract][Full Text] [Related]
19. Trends in Use of Prescription Nonsteroidal Anti-inflammatory Medications Before vs After Implementation of a Florida Law Restricting Opioid Prescribing for Acute Pain.
Keshwani S; Grande I; Maguire M; Goodin A; Vouri SM; Hincapie-Castillo JM
JAMA Netw Open; 2021 Jun; 4(6):e2113383. PubMed ID: 34115125
[TBL] [Abstract][Full Text] [Related]
20. Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML.
Chen EC; Fathi AT; Brunner AM
Onco Targets Ther; 2018; 11():3425-3434. PubMed ID: 29928134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
